Protective agents
Showing 51 - 75 of 8,256
COVID-19 Trial in Kampala (COVIDEX)
Not yet recruiting
- COVID-19
-
Kampala, UgandaMakerere University Department of Pharmacology and Therapeutics
Feb 14, 2022
Multiple Sclerosis Trial in Melsbroek
Completed
- Multiple Sclerosis
-
Melsbroek, Vlaams Brabant, BelgiumNationaal MS center
Apr 17, 2023
Infections, Oral Infection Trial (Suction)
Not yet recruiting
- Infections
- Oral Infection
- Suction
- (no location specified)
Apr 27, 2023
SARS CoV-2 Virus Secretions and Serum for Countermeasure
Recruiting
- Covid19
-
New Orleans, Louisiana
- +1 more
Jul 19, 2022
Metabolic Syndrome Trial in Gujranwala (Green Seaweed)
Enrolling by invitation
- Metabolic Syndrome
- Green Seaweed
-
Gujrānwāla, Punjab, PakistanAshraf Hospital
Mar 14, 2023
Breast Cancer Trial in Bani Suwayf, Fayoum (Atorvastatin 80mg, )
Recruiting
- Breast Cancer
- Atorvastatin 80mg
- placebo
-
Banī Suwayf, Egypt
- +1 more
Oct 31, 2022
Incontinence-associated Dermatitis Trial in Berlin (ESENTA™ Skin Barrier Spray (ConvaTec, UK), Hydrophobes Basisgel DAC)
Recruiting
- Incontinence-associated Dermatitis
- ESENTA™ Skin Barrier Spray (ConvaTec, UK)
- Hydrophobes Basisgel DAC
-
Berlin, GermanyCharité Universitätsmedizin Berlin
Oct 28, 2022
During Blood Pressure Changes Under General Anesthesia
Not yet recruiting
- General Anesthesia
- Diagnostic test - monitoring
-
Paris, FranceJoaquim MATEO
Apr 5, 2023
Vaccination, Hematopoietic Stem Cells Trial in Lyon, Pierre-Bénite (immune biomarkers to evaluate vaccine response in HSCT
Active, not recruiting
- Vaccination
- Hematopoietic Stem Cells
- immune biomarkers to evaluate vaccine response in HSCT recipients
-
Lyon, France
- +1 more
Jun 15, 2022
Inflammatory Markers in MI Patients
Not yet recruiting
- Myocardial Infarction
- Percutaneous coronary intervention
-
Bolu, Merkez, TurkeyBolu Abant Izzet University faculty of Medicine Department of Em
Jul 27, 2022
Infections, Urinary Tract, Nephrolithiasis Trial in San Francisco (Duration of antibiotics)
Not yet recruiting
- Infections, Urinary Tract
- Nephrolithiasis
- Duration of antibiotics
-
San Francisco, CaliforniaUniversity of California, San Francisco
Nov 20, 2023
Mucositis (MeSH Unique ID: D052016), Stomatitis (MeSH Unique ID: D013280) Trial (1. alpha acid lipoic - tables, 2. ozonated oil
Not yet recruiting
- Mucositis (MeSH Unique ID: D052016)
- Stomatitis (MeSH Unique ID: D013280)
- 1. alpha acid lipoic - tables
- +3 more
- (no location specified)
Jan 26, 2022
Burn Wounds Trial in New Orleans (SynePure Wound Cleanser and Catasyn Advanced Technology Hydrogel, SILVADENE Cream 1% (silver
Recruiting
- Burn Wounds
- SynePure Wound Cleanser and Catasyn Advanced Technology Hydrogel
- SILVADENE Cream 1% (silver sulfadiazine)
-
New Orleans, LouisianaLouisiana State University Health Science Center at New Orleans
May 17, 2023
Periodontitis Trial in Cairo (Lepidium Sativum, Simvastatin)
Completed
- Periodontitis
- Lepidium Sativum
- Simvastatin
-
Cairo, EgyptFaculty of Dentitry, Ain Shams University
Dec 10, 2022
Accidental Falls Trial in Baltimore (Physical Training Interventions)
Completed
- Accidental Falls
- Physical Training Interventions
-
Baltimore, Maryland
- +1 more
Sep 15, 2021
Atrial Fibrillation Paroxysmal Trial in Salt Lake City (Riluzole 50 MG)
Recruiting
- Atrial Fibrillation Paroxysmal
- Riluzole 50 MG
-
Salt Lake City, UtahUniversity of Utah
Nov 14, 2022
Breast Cancer, Peripheral Neuropathy, Cardiac Toxicities Trial in Tanta (Silymarin, Placebo)
Enrolling by invitation
- Breast Cancer
- +4 more
- Silymarin
- Placebo
-
Tanta, EgyptTanta university
Oct 22, 2022
Respiratory Insufficiency, Extracorporeal Membrane Oxygenation Complication, Mechanical Ventilation Pressure High Trial
Not yet recruiting
- Respiratory Insufficiency
- +2 more
- Ultra-protective ventilation facilitated by extracorporeal support
- Conventional lung-protective ventilation
- (no location specified)
Jun 27, 2022
Burns Trial in Shanghai (Cetirizine, Midazolam and Fentanyl)
Recruiting
- Burns
- Cetirizine
- Midazolam and Fentanyl
-
Shanghai, Shanghai, ChinaDepartment of Burn, Ruijin Hospital, Shanghai Jiao Tong Universi
Nov 6, 2023
Recurrent Aphthous Ulcer Trial in Rome (OR-AT0222, Placebo)
Recruiting
- Recurrent Aphthous Ulcer
- OR-AT0222
- Placebo
-
Rome, ItalyPoliclinico "Umberto I" - U.O.C. di Odontoiatria Pediatrica ed O
Jul 17, 2023
Brain Tumor, Metabolic Disturbance, Inflammatory Response Trial in Thessaloniki (Dexmedetomidine, Normal saline)
Completed
- Brain Tumor
- +3 more
- Dexmedetomidine
- Normal saline
-
Thessaloniki, GreeceAHEPA University Hospital
Feb 14, 2022
Covid19, SARS (Severe Acute Respiratory Syndrome) Trial in Tucumán (Ivermectin / Iota-Carrageenan)
Completed
- Covid19
- SARS (Severe Acute Respiratory Syndrome)
- Ivermectin / Iota-Carrageenan
-
Tucumán, ArgentinaSI.PRO.SA, Ministerio de Salud Pública
Feb 22, 2021
Diabetic Retinopathy Trial in Cairo (Dapagliflozin 10mg Tab plus another oral hypoglycemic agent, Two oral hypoglycemic agents
Recruiting
- Diabetic Retinopathy
- Dapagliflozin 10mg Tab plus another oral hypoglycemic agent
- Two oral hypoglycemic agents other than dapagliflozin
-
Cairo, EgyptInternal medicine and endocrinology department, Ain-shams univer
Jun 9, 2022